Anja Schmidt

727 total citations
19 papers, 578 citations indexed

About

Anja Schmidt is a scholar working on Hematology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Anja Schmidt has authored 19 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Anja Schmidt's work include Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Anja Schmidt is often cited by papers focused on Hemophilia Treatment and Research (7 papers), Platelet Disorders and Treatments (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Anja Schmidt collaborates with scholars based in Germany, United States and Switzerland. Anja Schmidt's co-authors include Christoph Königs, Ai-Hong Zhang, David W. Scott, John D. Willson, Richard W. Willy, Yong Chan Kim, Jeongheon Yoon, Martin Janz, Hans‐Dieter Royer and Manfred Schmitt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anja Schmidt

16 papers receiving 569 citations

Peers

Anja Schmidt
Hiroya Kanagawa Japan
Inês P. Perpétuo Portugal
Atsuhiro Fujie Japan
Elizabeth C. O’Quinn United States
Jana Riegger Germany
Bang Ung Youn South Korea
Carole Le Hénaff France
Feiwu Kang China
I. M. Dahl Norway
Hiroya Kanagawa Japan
Anja Schmidt
Citations per year, relative to Anja Schmidt Anja Schmidt (= 1×) peers Hiroya Kanagawa

Countries citing papers authored by Anja Schmidt

Since Specialization
Citations

This map shows the geographic impact of Anja Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Schmidt more than expected).

Fields of papers citing papers by Anja Schmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Schmidt. The network helps show where Anja Schmidt may publish in the future.

Co-authorship network of co-authors of Anja Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Schmidt. A scholar is included among the top collaborators of Anja Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Schmidt. Anja Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Meeks, Shannon L., Beatrice Nolan, Anja Schmidt, et al.. (2024). Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical, humoral and cellular immune responses. Therapeutic Advances in Hematology. 15. 1574218569–1574218569.
3.
Eckstein, Markus, Niklas Klümper, Anja Schmidt, et al.. (2023). CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression. Scientific Reports. 13(1). 73–73. 3 indexed citations
4.
Schmidt, Anja, et al.. (2022). The wastewater micropollutant carbamazepine in insectivorous birds—an exposure estimate. Analytical and Bioanalytical Chemistry. 414(17). 4909–4917. 13 indexed citations
5.
Schmidt, Anja, et al.. (2021). CD4+ regulatory and naïve T cells specific for factor VIII stand vis‐à‐vis to balance the immune response in healthy individuals. SHILAP Revista de lepidopterología. 2(4). 805–808. 2 indexed citations
6.
Schmidt, Anja, et al.. (2020). Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression. Cellular Immunology. 358. 104222–104222. 59 indexed citations
7.
Klümper, Niklas, Johannes Stein, Doris Schmidt, et al.. (2020). Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers. Cancers. 12(11). 3439–3439. 6 indexed citations
8.
Schmidt, Anja, et al.. (2018). Elimination of factor VIII‐specific B cells by immunotoxins composed of a single factor VIII domain fused to Pseudomonas exotoxin A. Journal of Thrombosis and Haemostasis. 16(11). 2223–2232. 2 indexed citations
9.
Yoon, Jeongheon, Anja Schmidt, Ai-Hong Zhang, et al.. (2016). FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII. Blood. 129(2). 238–245. 121 indexed citations
10.
Schmidt, Anja, et al.. (2016). Regulatory T cells and their potential for tolerance induction in haemophilia A patients. Hämostaseologie. 36(S 02). S5–S12.
11.
Schmidt, Anja, et al.. (2016). Neutralisation of factor VIII inhibitors by anti-idiotypes isolated from phage-displayed libraries. Thrombosis and Haemostasis. 116(7). 32–41. 4 indexed citations
12.
Schmidt, Anja, Thomas Klingebiel, John F. Healey, et al.. (2015). Frequency and Epitope Specificity of Anti-Factor VIII C1 Domain Antibodies in Acquired and Hereditary Hemophilia Inhibitor Patient Plasma. Blood. 126(23). 3491–3491. 1 indexed citations
13.
Willy, Richard W., et al.. (2015). In‐field gait retraining and mobile monitoring to address running biomechanics associated with tibial stress fracture. Scandinavian Journal of Medicine and Science in Sports. 26(2). 197–205. 125 indexed citations
14.
Schmidt, Anja, et al.. (2015). Immunosuppressive FVIII-Specific Human Cartregs in Hemophilia a. Blood. 126(23). 291–291. 1 indexed citations
15.
16.
White, Leonard A., et al.. (2007). A phase II study of docetaxel (D) plus imatinib (I) in patients with previously treated non-small cell lung cancer. Journal of Clinical Oncology. 25(18_suppl). 18200–18200. 2 indexed citations
17.
Mielke, Stephan, K. Mross, Thomas Alexander Gerds, et al.. (2003). Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h. Anti-Cancer Drugs. 14(10). 785–792. 31 indexed citations
18.
Mielke, Stephan, K. Mross, Thomas Alexander Gerds, et al.. (2003). 542 A multicenter, randomized phase III study on neurotoxicity, safety and efficacy of weekly Pacilitaxel infused over 1-h vs. 3-h in patients with advanced solid tumors. European Journal of Cancer Supplements. 1(5). S164–S164. 2 indexed citations
19.
Janz, Martin, Nadia Harbeck, P. Dettmar, et al.. (2001). Y‐box factor YB‐1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI‐1. International Journal of Cancer. 97(3). 278–282. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroya Kanagawa Breakdown of academic impact, for papers by Inês P. Perpétuo Breakdown of academic impact, for papers by Atsuhiro Fujie Breakdown of academic impact, for papers by Elizabeth C. O’Quinn Breakdown of academic impact, for papers by Jana Riegger Breakdown of academic impact, for papers by Bang Ung Youn Breakdown of academic impact, for papers by Carole Le Hénaff Breakdown of academic impact, for papers by Feiwu Kang Breakdown of academic impact, for papers by I. M. Dahl
Rankless by CCL
2026